HISTAMINE-RELEASING PROPERTIES OF HYDROXY-9-METHYL-2-ELLIPTICINIUM ACETATE

被引：8
|
作者：
ESCHALIER, A
ADVENIER, C
LEBEL, B
BURTIN, C
LAVARENNE, J
机构：
[1] FAC MED NECKER ENFANTS MALADES, PHARMACOL LAB, F-75015 PARIS, FRANCE
[2] FAC MED NECKER ENFANTS MALADES, PATHOL EXPTL LAB, INSERM, FORMAT RECH 3, F-75015 PARIS, FRANCE
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1981年 / 5卷 / 04期
关键词：
D O I：
10.1007/BF00434390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 236
页数：4
相关论文
共 50 条
  • [31] PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS
    JURET, P
    TANGUY, A
    GIRARD, A
    LETALAER, JY
    ABBATUCCI, JS
    DATXUONG, N
    LEPECQ, JB
    PAOLETTI, C
    EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) : 205 - 206
  • [32] HISTAMINE-RELEASING ACTIVITY (HRA) .2. INTERACTION WITH BASOPHILS AND PHYSICOCHEMICAL CHARACTERIZATION
    THUESON, DO
    SPECK, LS
    LETTBROWN, MA
    GRANT, JA
    JOURNAL OF IMMUNOLOGY, 1979, 123 (02) : 633 - 639
  • [33] PHASE-II STUDY OF 9-HYDROXY-METHYL-ELLIPTICINIUM (9-HME) IN ADVANCED SOLID TUMORS
    CLARYSSE, A
    BRUGAROLAS, A
    SIEGENTHALER, P
    JAGER, RD
    CAVALLI, F
    ALBERTO, P
    HANSEN, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 348 - 348
  • [34] IONOPHORE PROPERTIES AND HISTAMINE-RELEASING ACTION OF POLYETHER ANTIBIOTIC OMOMYCIN (985-I)
    ZEBREV, AI
    ANTONENKO, YN
    GUSHCHIN, IS
    VOITENKO, VG
    IVANITSKAYA, LP
    KOROBKOVA, TP
    KUDINOVA, MK
    MURENETS, NV
    IVANOVA, TA
    DROBYSHEVA, TN
    RYAZANTSEV, GB
    FEDOSEEV, VM
    BIOLOGICHESKIE MEMBRANY, 1986, 3 (12): : 1224 - 1231
  • [35] 9-HYDROXY METHYL ELLIPTICINIUM (9 HME, NSC 264137) - PHASE-I CLINICAL-STUDY
    BRUGAROLAS, A
    GRACIA, M
    JAGER, RD
    MALLARME, M
    CLARYSSE, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 310 - 310
  • [36] 2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE (ELLIPTICINIUM) IN THE TREATMENT OF LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE-II STUDY
    TURA, S
    MANDELLI, F
    MAZZA, P
    CIMINO, G
    ANSELMO, AP
    AMADORI, S
    CHEMIOTERAPIA, 1984, 3 (02): : 79 - 82
  • [37] ISOLATION OF A HISTAMINE-RELEASING FACTOR FROM 2-CELL HUMAN-EMBRYO
    COCCHIARA, R
    DITRAPANI, G
    AZZOLINA, A
    ALBEGGIANI, G
    GERACI, D
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 84 (03): : 321 - 323
  • [38] PHASE-I CLINICAL-STUDY OF 9-HYDROXY-2N-METHYL-ELLIPTICINIUM ACETATE (NSC-264137) ADMINISTERED ON A 5-DAY IV SCHEDULE
    DODION, P
    ROZENCWEIG, M
    NICAISE, C
    PICCART, M
    CUMPS, E
    CRESPEIGNE, N
    KISNER, D
    KENIS, Y
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (06): : 519 - &
  • [39] HISTAMINE-RELEASING PROPERTIES OF POLYSORBATE-80 INVITRO AND INVIVO - CORRELATION WITH ITS HYPOTENSIVE ACTION IN THE DOG
    MASINI, E
    PLANCHENAULT, J
    PEZZIARDI, F
    GAUTIER, P
    GAGNOL, JP
    AGENTS AND ACTIONS, 1985, 16 (06): : 470 - 477
  • [40] IRREVERSIBLE FIXATION OF 2N-METHYL-9-HYDROXY-ELLIPTICINIUM (NMHE, CELIPTIUM) ON DNA IN L1210 CELLS IN CULTURE AND INVITRO
    AUCLAIR, C
    PAOLETTI, C
    DUGUE, B
    MEUNIER, B
    BULLETIN DU CANCER, 1986, 73 (04) : 405 - 405
12345